Ypsomed

Ypsomed

Verified
Innovative, high-quality and reliable products and services which allow patients to administer their own medication in a safe and simple way

Launch date
Employees
Ownership
Market cap
CHF1.7b
Net debt
CHF26.3m
Firm valuation
$2.0b (Public information from 2022)
Bern Canton of Bern (HQ)
Deals in current and previous year:

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues-325m388m378m328m337m392m
% growth--19 %(3 %)(13 %)3 %16 %
EBITDA-72.5m79.2m98.3m51.7m54.2m85m
% EBITDA margin-22 %20 %26 %16 %16 %22 %
Profit-38.3m43.3m50m9.2m4.2m25m
% profit margin-12 %11 %13 %3 %1 %6 %
EV / revenue-6.2x4.0x3.8x4.4x5.4x4.6x
EV / EBITDA-27.4x19.6x14.5x28.1x33.6x21.4x
R&D budget36m45m54m76m---
R&D % of revenue-14 %14 %20 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
N/AN/AIPO
Total Funding-

Recent News about Ypsomed

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Ypsomed

Edit